Nipah research to support vaccine development
A new study will seek to understand the body’s response to the Nipah virus in order to support development of vaccines.
Archives for March 28, 2022
AstraZeneca’s COVID-19 preventative drug secures EU approval
AstraZeneca's Evusheld has been approved in the EU for the prevention of COVID-19 in adults and teens 12 years and older weighing at least 40 kg.
CytoImmune Therapeutics opens clinical cell manufacturing facility in Puerto Rico
CytoImmune Therapeutics, a clinical-stage immunotherapy company developing a novel class of engineered natural killer (NK) cell-based cancer therapies, has announced the opening of its clinical cell manufacturing facility in Toa Baja, Puerto Rico.
EU: Janssen’s multiple myeloma therapy set for approval, Kymriah on track for extra indication
Janssen’s Carvykti, a therapy for multiple myeloma, has been approved for conditional marketing authorization (CMA) by the European Medicines Agency (EMA).